Impact of glycans on T-cell tolerance to glycosylated self-antigens

Immunology and Cell Biology

Volumn 86, Issue 7, 2008, Pages 574-579

  Purcell, Anthony W ^a   Van Driel, Ian R ^a   Gleeson, Paul A ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Carbohydrate; Glycans; Immune tolerance; T cell recognition

Indexed keywords

CARBOHYDRATE; EPITOPE; GLYCAN DERIVATIVE; GLYCOPEPTIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ANTIGEN PRESENTATION; AUTOIMMUNE DISEASE; GLYCOSYLATION; HUMAN; IN VIVO STUDY; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PROTEIN BINDING; PROTEIN PURIFICATION; REVIEW; T LYMPHOCYTE;

AUTOANTIGENS; AUTOIMMUNE DISEASES; GLYCOSYLATION; HUMANS; IMMUNE TOLERANCE; POLYSACCHARIDES; T-LYMPHOCYTES;

EID: 53249085819     PISSN: 08189641     EISSN: 14401711     Source Type: Journal    
DOI: 10.1038/icb.2008.48     Document Type: Review

References (80)

1. Anderton SM. Post-translational modifications of self antigens: implications for autoimmunity. Curr Opin Immunol 2004; 16: 753-758.
2. Engelhard VH, Altrich-Vanlith M, Ostankovitch M, Zarling AL. Post-translational modifications of naturally processed MHC-binding epitopes. Curr Opin Immunol 2006; 18: 92-97.
3. Rudd PM, Elliott T, Cresswell P, Wilson IA, Dwek RA. Glycosylation and the immune system. Science 2001; 291: 2370-2376.
4. Crocker PR, Paulson JC, Varki A. Siglecs and their roles in the immune system. Nat Rev Immunol 2007; 7: 255-266.
5. Gringhuis SI, den Dunnen J, Litjens M, van Het Hof B, van Kooyk Y, Geijtenbeek TB. C-type lectin DC-SIGN modulates Toll-like receptor signaling via Raf-1 kinase-dependent acetylation of transcription factor NF-kappaB. Immunity 2007; 26: 605-616.
6. van Vliet SJ, den Dunnen J, Gringhuis SI, Geijtenbeek TB, van Kooyk Y. Innate signaling and regulation of Dendritic cell immunity. Curr Opin Immunol 2007; 19: 435-440.
7. Siggs OM, Makaroff LE, Liston A. The why and how of thymocyte negative selection. Curr Opin Immunol 2006; 18: 175-183.
8. Steinman RM, Hawiger D, Nussenzweig MC. Tolerogenic dendritic cells. Annu Rev Immunol 2003; 21: 685-711.
9. van Driel IR, Read S, Zwar TD, Gleeson PA. Shaping the T cell repertoire to a bona fide autoantigen: lessons from autoimmune gastritis. Curr Opin Immunol 2005; 17: 570-576.
10. Read S, Hogan TV, Zwar TD, Gleeson PA, Van Driel IR. Prevention of autoimmune gastritis in mice requires extra-thymic T-cell deletion and suppression by regulatory T cells. Gastroenterology 2007; 133: 547-558.
11. Heath WR, Carbone FR. Cross-presentation, dendritic cells, tolerance and immunity. Annu Rev Immunol 2001; 19: 47-64.
12. Cloosen S, Arnold J, Thio M, Bos GM, Kyewski B, Germeraad WT. Expression of tumor-associated differentiation antigens MUC1 glycoforms and CEA, in human thymic epithelial cells: implications for self-tolerance and tumor therapy. Cancer Res 2007; 67: 3919-3926.
13. Haltiwanger RS, Blomberg MA, Hart GW. Glycosylation of nuclear and cytoplasmic proteins. Purification and characterization of a uridine diphospho-N-acetylglucosamine: polypeptide beta-N-acetylglucosaminyltransferase. J Biol Chem 1992; 267: 9005-9013.
14. Hart GW. Dynamic O-linked glycosylation of nuclear and cytoskeletal proteins. Annu Rev Biochem 1997; 66: 315-335.
15. Skipper JC, Hendrickson RC, Gulden PH, Brichard V, Van Pel A, Chen Y et al. An HLA-A2-restricted tyrosinase antigen on melanoma cells results from posttranslational modification and suggests a novel pathway for processing of membrane proteins. J Exp Med 1996; 183: 527-534.
16. Carbone FR, Gleeson PA. Carbohydrates and antigen recognition by T cells. Glycobiology 1997; 7: 725-730.
17. Zajonc DM, Kronenberg M. CD1 mediated T cell recognition of glycolipids. Curr Opin Struct Biol 2007; 17: 521-529.
18. Borg NA, Wun KS, Kjer-Nielsen L, Wilce MC, Pellicci DG, Koh R et al. CD1d-lipid-antigen recognition by the semi-invariant NKT T-cell receptor. Nature 2007; 448: 44-49.
19. Cobb BA, Wang Q, Tzianabos AO, Kasper DL. Polysaccharide processing and presentation by the MHCII pathway. Cell 2004; 117: 677-687.
20. Ishioka GY, Lamont AG, Thomson D, Bulbow N, Gaeta FC, Sette A et al. MHC interaction and T cell recognition of carbohydrates and glycopeptides. J Immunol 1992; 148: 2446-2451.
21. Rammensee H-G, Friede T, Stevanovic S. MHC ligands and peptide motifs:first listing. Immunogenetics 1995; 41: 178-228.
22. Haurum JS, Hoier IB, Arsequell G, Neisig A, Valencia G, Zeuthen J et al. Presentation of cytosolic glycosylated peptides by human class I major histocompatibility complex molecules in vivo. J Exp Med 1999; 190: 145-150.
23. Villadangos JA, Heath WR, Carbone FR. Outside looking in: the inner workings of the cross-presentation pathway within dendritic cells. Trends Immunol 2007; 28: 45-47.
24. Meusser B, Hirsch C, Jarosch E, Sommer T. ERAD: the long road to destruction. Nat Cell Biol 2005; 7: 766-772.
25. Kario E, Tirosh B, Ploegh HL, Navon A. N-linked glycosylation does not impair proteasomal degradation but affects class I major histocompatibility complex presentation. J Biol Chem 2008; 283: 244-254.
26. Ninkovic T, Hanisch FG. O-glycosylated human MUC1 repeats are processed in vitro by immunoproteasomes. J Immunol 2007; 179: 2380-2388.
27. Chicz RM, Urban RG, Gorga JC, Vignali DAA, Lane WS, Strominger JL. Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles. J Exp Med 1993; 178: 27-47.
28. Drummer HE, Jackson DC, Brown LE. Modulation of CD4+ T-cell recognition of influenza hemagglutinin by carbohydrate side chains located outside a T-cell determinant. Virology 1983; 192: 282-289.
29. Haurum JS, Tan L, Arsequell G, Frodsham P, Lellouch AC, Moss PA et al. Peptide achor residue glycosylation: effect on class I major histocompatibility complex binding and cytotoxic T lymphocyte recognition. Eur J Immunol 1995; 25: 3270-3276.
30. Jensen T, Galli-Stampino L, Mouritsen S, Frische K, Peters S, Meldal M et al. T cell recognition of Tn-glycosylated peptide antigens. Eur J Immunol 1996; 26: 1342-1349.
31. Harding CV, Kihlberg J, Elofsson M, Magnusson G, Unanue ER. Glycopeptides bind to MHC molecules and elicit specific T cell responses. J Immunol 1993; 151: 2419-2425.
32. Haurum JS, Arsequell G, Lellouch AC, Wong SY, Dwek RA, McMichael AJ et al. Recognition of carbohydrate by major histocompatility complex class I-restricted, glycopeptide-specific cytotoxic T lymphocytes. J Exp Med 1994; 180: 739-744.
33. Michaëlsson E, Malmström V, Reis S, Engström A, Burkhardt H, Holmdahl R. T cell recognition of carbohydrates on type II collagen. J Exp Med 1994; 180: 745-749.
34. Dengjel J, Rammensee HG, Stevanovic S. Glycan side chains on naturally presented MHC class II ligands. J Mass Spectrom 2005; 40: 100-104.
35. Dudler T, Altmann F, Carballido JM, Blaser K. Carbohydrate-dependent HLA class II-restricted, human T cell response to the bee venom allergen phospholipase A2 in allergic patients. Eur J Immunol 1995; 25: 538-542.
36. Apostolopoulos V, Yuriev E, Ramsland PA, Halton J, Osinski C, Li Wet al. A glycopeptide in complex with MHC class I uses the GalNAc residue as an anchor. Proc Natl Acad Sci USA 2003; 100: 15029-15034.
37. Deck B, Elofsson M, Kihlberg J, Unanue ER. Specificity of glycopeptide-specific T cells. J Immunol 1995; 155: 1074-1078.
38. Harding CV, Kihlberg J, Elofsson M, Magnusson G, Unanue ER. Glycopeptides bind MHC molecules and elicit specific T cell responses. J Immunol 1993; 151: 2419-2425.
39. Michaelsson E, Broddefalk J, Engstrom A, Kihlberg J, Holmdahl R. Antigen processing and presentation of a naturally glycosylated protein elicits major histocompatibility complex class II-restricted, carbohydrate-specific T cells. Eur J Immunol 1996; 26: 1906-1910.
40. Dzhambazov B, Holmdahl M, Yamada H, Lu S, Vestberg M, Holm B et al. The major T cell epitope on type II collagen is glycosylated in normal cartilage but modified by arthritis in both rats and humans. Eur J Immunol 2005; 35: 357-366.
41. Williamson NA, Purcell AW. Use of proteomics to define targets of T-cell immunity. Expert Rev Proteomics 2005; 2: 367-380.
42. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N et al. Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 1992; 255: 1261-1263.
43. Zarling AL, Ficarro SB, White FM, Shabanowitz J, Hunt DF, Engelhard VH. Phosphorylated peptides are naturally processed and presented by major histocompatibility complex class I molecules in vivo. J Exp Med 2000; 192: 1755-1762.
44. Purcell AW, Gorman JJ. Immunoproteomics: Mass Spectrometry-based Methods to Study the Targets of the Immune Response. Mol Cell Proteomics 2004; 3: 193-208.
45. Tang WH, Hunter CL, Rooney FR, Williamson NA, Purcell AW. Assessing the proportion of post-translationally modified peptides in the immunopeptidome. HUPO 5th Annual World Congress, 2006, 50.
46. Wuhrer M. Glycosylation profiling in clinical proteomics: heading for glycan biomarkers. Expert Rev Proteomics 2007; 4: 135-136.
47. Miyamoto S. Clinical applications of glycomic approaches for the detection of cancer and other diseases. Curr Opin Mol Ther 2006; 8: 507-513.
48. Bond MR, Kohler JJ. Chemical methods for glycoprotein discovery. Curr Opin Chem Biol 2007; 11: 52-58.
49. Geyer H, Geyer R. Strategies for analysis of glycoprotein glycosylation. Biochim Biophys Acta 2006; 1764: 1853-1869.
50. Plavina T, Wakshull E, Hancock WS, Hincapie M. Combination of abundant protein depletion and multi-lectin affinity chromatography (M-LAC) for plasma protein biomarker discovery. J Proteome Res 2007; 6: 662-671.
51. Madera M, Mechref Y, Klouckova I, Novotny MV. High-sensitivity profiling of glycoproteins from human blood serum through multiple-lectin affinity chromatography and liquid chromatography/tandem mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci 2007; 845: 121-137.
52. Qiu R, Regnier FE. Use of multidimensional lectin affinity chromatography in differential glycoproteomics. Anal Chem 2005; 77: 2802-2809.
53. Yang Z, Hancock WS, Chew TR, Bonilla L. A study of glycoproteins in human serum and plasma reference standards (HUPO) using multilectin affinity chromatography coupled with RPLC-MS/MS. Proteomics 2005; 5: 3353-3366.
54. Sandra K, Devreese B, Van Beeumen J, Stals I, Claeyssens M. The Q-Trap mass spectrometer a novel tool in the study of protein glycosylation. J Am Soc Mass Spectrom 2004; 15: 413-423.
55. Jiang H, Desaire H, Butnev VY, Bousfield GR. Glycoprotein profiling by electrospray mass spectrometry. J Am Soc Mass Spectrom 2004; 15: 750-758.
56. Jebanathirajah J, Steen H, Roepstorff P. Using optimized collision energies and high resolution, high accuracy fragment ion selection to improve glycopeptide detection by precursor ion scanning. J Am Soc Mass Spectrom 2003; 14: 777-784.
57. Ritchie MA, Gill AC, Deery MJ, Lilley K. Precursor ion scanning for detection and structural characterization of heterogeneous glycopeptide mixtures. J Am Soc Mass Spectrom 2002; 13: 1065-1077.
58. Christen U, von Herrath MG. Initiation of autoimmunity. Curr Opin Immunol 2004; 16: 759-767.
59. Goodnow CC. Multistep pathogenesis of autoimmune disease. Cell 2007; 130: 25-35.
60. von Herrath MG, Fujinami RS, Whitton JL. Microorganisms and autoimmunity: making the barren field fertile? Nat rev 2003; 1: 151-157.
61. Marsland BJ, Kopf M. Toll-like receptors: paving the path to T cell-driven autoimmunity? Curr Opin Immunol 2007; 19: 611-614.
62. Steinman RM, Nussenzweig MC. Avoiding horror autotoxicus: the importance of dendritic cells in peripheral T cell tolerance. Proc Natl Acad Sci USA 2002; 99: 351-358.
63. Bond A, Alavi A, Axford JS, Bourke BE, Bruckner FE, Kerr MA et al. A detailed lectin analysis of IgG glycosylation, demonstrating disease specific changes in terminal galactose and N-acetylglucosamine. J Autoimmun 1997; 10: 77-85.
64. Gleeson PA. Glycoconjugates in autoimmunity. Bba-Rev Biomembranes 1994; 1197: 237-255.
65. Gornik O, Royle L, Harvey DJ, Radcliffe CM, Saldova R, Dwek RA et al. Changes of serum glycans during sepsis and acute pancreatitis. Glycobiology 2007; 17: 1321-1332.
66. Piagnerelli M, Boudjeltia KZ, Nuyens V, De Backer D, Su F, Wang Z et al. Rapid alterations in transferrin sialylation during sepsis. Shock (Augusta, Ga) 2005; 24: 48-52.
67. Groux-Degroote S, Krzewinski-Recchi MA, Cazet A, Vincent A, Lehoux S, Lafitte JJ et al. IL-6 and IL-8 increase the expression of glycosyltransferases and sulfotransferases involved in the biosynthesis of sialylated and/or sulfated Lewisx epitopes in the human bronchial mucosa. Biochem J 2008; 410: 213-223.
68. Rook G, Thompson S, Buckley M, Elson C, Brealey R, Lambert C et al. The role of oil and agalactosyl IgG in the induction of arthritis in rodent models. Eur J Immunol 1991; 21: 1027-1032.
69. Thompson SJ, Hitsumoto Y, Zhang YW, Rook GA, Elson CJ. Agalactosyl IgG in pristane-induced arthritis. Pregnancy affects the incidence and severity of arthritis and the glycosylation status of IgG. Clin Exp Immunol 1992; 89: 434-438.
70. Bouneaud C, Kourilsky P, Bousso P. Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 2000; 13: 829-840.
71. de Visser KE, Cordaro TA, Kioussis D, Haanen JB, Schumacher TN, Kruisbeek AM. Tracing and characterization of the low-avidity self-specific T cell repertoire. Eur J Immunol 2000; 30: 1458-1468.
72. Laurie KL, Van Driel IR, Zwar TD, Barrett SP, Gleeson PA. Endogenous H/K ATPase beta-subunit promotes T cell tolerance to the immunodominant gastritogenic determinant. J Immunol 2002; 169: 2361-2367.
73. Lee DS, Ahn C, Ernst B, Sprent J, Surh CD. Thymic selection by a single MHC/peptide ligand: autoreactive T cells are low-affinity cells. Immunity 1999; 10: 83-92.
74. Backlund J, Carlsen S, Hoger T, Holm B, Fugger L, Kihlberg J et al. Predominant selection of T cells specific for the glycosylated collagen type II epitope (263-270) in humanized transgenic mice and in rheumatoid arthritis. Proc Natl Acad Sci USA 2002; 99: 9960-9965.
75. Backlund J, Treschow A, Bockermann R, Holm B, Holm L, Issazadeh-Navikas S et al. Glycosylation of type II collagen is of major importance for T cell tolerance and pathology in collagen-induced arthritis. Eur J Immunol 2002; 32: 3776-3784.
76. Corthay A, Backlund J, Broddefalk J, Michaëlsson E, Goldschmidt TJ, Kihlberg J et al. Epitope glycosylation plays a critical role for T cell recognition of type II collagen in collagen-induced arthritis. Eur J Immunol 1998; 28: 2580-2590.
77. Biol MC, Martin A, Louisot P. Nutritional and developmental regulation of glycosylation processes in digestive organs. Biochimie 1992; 74: 13-24.
78. Marquardt T, Luhn K, Srikrishna G, Freeze HH, Harms E, Vestweber D. Correction of leukocyte adhesion deficiency type II with oral fucose. Blood 1999; 94: 3976-3985.
79. Niehues R, Hasilik M, Alton G, Körner C, Schiebe-Sukumar M, Koch HG et al. Carbohydrate-deficient glycoprotein syndrome type Ib. Phosphomannose isomerase deficiency and mannose therapy. J Clin Invest 1998; 101: 1414-1420.
80. Lau KS, Partridge EA, Grigorian A, Silvescu CI, Reinhold VN, Demetriou M et al. Complex N-glycan number and degree of branching cooperate to regulate cell proliferation and differentiation. Cell 2007; 129: 123-134.